Effect of CPAP on Blood Pressure in Patients With Sleep Apnea and Refractory Hypertension
NCT ID: NCT00863135
Last Updated: 2017-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
68 participants
INTERVENTIONAL
2008-12-31
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Also, some of the mechanisms mediating SAS and RAH (systemic inflammation, oxidative stress, sympathetic hyperactivity) will be analyzed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep Apnea and Refractory Hypertension: Prevalence and Effect of CPAP Treatment
NCT00459914
Effect of Continuous Positive Airway Pressure (CPAP) Treatment in the Control of Refractory Hypertension
NCT00616265
Effect of Continuous Positive Airway Pressure (CPAP) on Hypertension and Cardiovascular Morbidity-Mortality in Patients With Sleep Apnea and no Daytime Sleepiness
NCT00127348
Effects of Continuous Positive Airway Pressure (CPAP) in Patients With Resistant Hypertension and Obstructive Sleep Apnea (OSA)
NCT00812695
Efficacy of CPAP Treatment on Blood Pressure of Resistant Hypertension Patients With Obstructive Sleep Apnea Syndrome
NCT01508754
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Continuous Positive Airway Pressure
nocturnal continuous positive airways pressure
CPAP
continuous positive airways pressure
Control
Waiting list,3 months without any change in their treatment, come into the CPAP procedure after that time
Control
Patients are 3 months without any change in their treatment, and are in the waiting list to come into the CPAP procedure after that time
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CPAP
continuous positive airways pressure
Control
Patients are 3 months without any change in their treatment, and are in the waiting list to come into the CPAP procedure after that time
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* professional drivers
* secondary arterial hypertension
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Carlos III Health Institute
OTHER_GOV
Corporacion Parc Tauli
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jaume Almirall
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jaume Almirall, Dr
Role: PRINCIPAL_INVESTIGATOR
Corporació Parc Taulí
Juan-Carlos Martinez-Ocaña, Dr
Role: STUDY_CHAIR
Corporació Parc Tauli
Antonio Ferrer, Dr
Role: STUDY_CHAIR
Corporacio Parc Tauli
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Corporacio Parc Tauli
Sabadell, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FIS PI070219
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.